+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, World News Story Pfizer Biontech To Seek Emergency Vaccine Approval In Us Friday is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


World News Story Pfizer Biontech To Seek Emergency Vaccine Approval In Us Friday | RobinsPost News & Noticias

GSK Sues Pfizer, BioNTech for Share of Billions in Vaccine Sales


GlaxoSmithKline filed a federal lawsuit seeking to recoup a share of the tens of billions of dollars in revenue Pfizer and BioNTech have reported from sales of their Covid-19 vaccines, which GSK ... Read More

GlaxoSmithKline Sues Pfizer and BioNTech Over Covid-19 Vaccine Technology


(Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' ... Read More

Pfizer to seek approval for RSV vaccine for people as young as 18


An RSV vaccine already used for older adults could help protect people as young as 18 who are at increased risk of the disease, drugmaker Pfizer said in a news release Tuesday. The company said it ... Read More

Moderna, Pfizer/BioNTech set for UK court clash over Covid jab patents


A row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday over patents for Covid vaccine technology that helped save millions of lives during the pandemic. At ... Read More

Pfizer to seek approval for RSV vaccine for people as young as 18


(CNN) — An RSV vaccine already used for older adults could help protect people as young as 18 who are at increased risk of the disease, drugmaker Pfizer said in a news release Tuesday. Read More

Pfizer to seek approval for RSV vaccine for people as young as 18


drugmaker Pfizer said in a news release Tuesday. The company said it would submit the information to the US Food and Drug Administration for potential expansion of the vaccine’s availability to ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus